Literature DB >> 8471772

Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice.

L L Peters1, L C Turtzo, C S Birkenmeier, J E Barker.   

Abstract

Mice homozygous for the mutation normoblastosis (gene symbol nb on chromosome 8) are deficient in erythroid ankyrin (ANK-1) and have a severe hemolytic anemia throughout life. Characteristic of the disease is a dramatic decrease in the level of expression of the Ank-1 gene (chromosome 8). The other major ankyrin transcript, brain ankyrin (Ank-2 on chromosome 3) is expressed at normal levels in nb/nb mice. Surprisingly, nb/nb fetuses have normal erythrocyte counts despite the decreased levels of Ank-1 transcripts. We previously hypothesized that fetal-specific ankyrin-related proteins could exist in nb/nb fetuses to account for the lack of detrimental effects of ANK-1 deficiency. In the present report, Western and Northern blot analyses were performed on hematopoietic cells isolated from nb/nb and +/+ fetuses. An ANK-1-related protein (165 Kd) in fetal reticulocytes persisted in adult nb/nb but not in +/+ reticulocytes. An Ank-1-related transcript of 5.5 kb was found in fetal reticulocytes. This transcript appeared to be upregulated in nb/nb but not in +/+ adult reticulocytes. A fetal-specific ANK-2-related protein (155 Kd) was present in nb/nb and in +/+ fetal reticulocytes. Ank-2-related fetal liver mRNAs were present during the time the liver was actively generating erythrocytes. Neither the Ank-2-related transcripts nor the 155-Kd ANK-2-related protein were found in +/+ or mutant adult reticulocytes. The data indicate that (1) unique ankyrin-related proteins and mRNAs present in fetal erythrocytes may stabilize the ankyrin-deficient nb/nb erythrocytes and (2) adult nb/nb mice may upregulate fetal gene transcripts to compensate for the ANK-1 deficiency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471772

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide.

Authors:  M L Howell; E Alsabbagh; J F Ma; U A Ochsner; M G Klotz; T J Beveridge; K M Blumenthal; E C Niederhoffer; R E Morris; D Needham; G E Dean; M A Wani; D J Hassett
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

2.  A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis.

Authors:  Michael R Hughes; Nicole Anderson; Steven Maltby; Justin Wong; Zorana Berberovic; Connie S Birkenmeier; D James Haddon; Kamal Garcha; Ann Flenniken; Lucy R Osborne; S Lee Adamson; Janet Rossant; Luanne L Peters; Mark D Minden; Robert F Paulson; Chen Wang; Dwayne L Barber; Kelly M McNagny; William L Stanford
Journal:  Exp Hematol       Date:  2010-12-28       Impact factor: 3.084

3.  Genome-Wide Identification and Functional Analysis of the bZIP Transcription Factor Family in Rice Bakanae Disease Pathogen, Fusarium fujikuroi.

Authors:  Kehan Zhao; Lianmeng Liu; Shiwen Huang
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

4.  Ankyrin and beta-spectrin accumulate independently of alpha-spectrin in Drosophila.

Authors:  R R Dubreuil; J Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  Intracisternal A-particle element transposition into the murine beta-glucuronidase gene correlates with loss of enzyme activity: a new model for beta-glucuronidase deficiency in the C3H mouse.

Authors:  B Gwynn; K Lueders; M S Sands; E H Birkenmeier
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

6.  Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle.

Authors:  D Zhou; C S Birkenmeier; M W Williams; J J Sharp; J E Barker; R J Bloch
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.